Enteric fever, encompassing both typhoid and paratyphoid fever, remains a significant global health issue, particularly in low-resource settings. Despite advancements in diagnostic techniques and treatment strategies, challenges persist in managing this condition. This article aims to provide an updated approach to the diagnosis and management of enteric fever in clinical practice.
Early diagnosis of enteric fever is crucial to prevent complications and reduce morbidity. While blood culture remains the gold standard, it has limitations, such as low sensitivity and slow turnaround time. Recent advances include molecular techniques like PCR and serological tests like Typhidot and Tubex TF, which offer more rapid results. However, their utility is limited by variable sensitivity and specificity. Therefore, a high index of clinical suspicion and comprehensive patient history remain vital in guiding the diagnostic process.
The mainstay of enteric fever management is antibiotic therapy. The choice of antibiotics depends on local antimicrobial resistance patterns. Fluoroquinolones, cephalosporins, and azithromycin are commonly used. However, the emergence of extensively drug-resistant (XDR) strains poses a significant challenge, necessitating the use of newer agents like carbapenems and tigecycline.
Vaccination plays a crucial role in the prevention of enteric fever. Two vaccines, Vi polysaccharide vaccine and Ty21a, are currently available and recommended for high-risk individuals and travelers to endemic areas. Additionally, improving sanitation, safe food and water practices, and public health surveillance are essential in controlling the disease.
Enteric fever continues to pose a significant global health challenge. While advances have been made in diagnostic techniques and treatment strategies, vigilance in clinical suspicion, awareness of local antimicrobial resistance patterns, and preventive measures remain key to managing this disease effectively. Further research is needed to develop more sensitive and specific diagnostic tests and to address the growing concern of antibiotic resistance.
1.
Report: Breast cancer mortality continues three decade decline, but steeper increases in incidence for some women
2.
Chronic pain and poor sleep are troublesome bed partners.
3.
Retired Olympic athletes at greater risk of skin cancer and osteoarthritis, research reveals
4.
Upfront TKI for Bone-Predominant RCC Tops Single-Agent Immunotherapy
5.
New study elucidates obesity's role in fueling breast cancer progression
1.
A Closer Look at MCV Modules: Features, Functions, and Benefits
2.
Minimal Residual Disease Monitoring: Advances, Clinical Relevance, and Guideline-Based Perspectives
3.
Ethics of Experimental Oncology: Case Study on Autonomy, Consent & Decision-Making
4.
The Role of Calcium Corrections in Accurate Blood Test Results
5.
Oncology Drug Handling Near-Misses: Clinical Risks, Pathophysiology, and Guideline-Based Approaches
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
1.
Current Scenario of Blood Cancer- Genomic Testing & Advancement in Diagnosis and Treatment
2.
Future of Hematology
3.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I
4.
Efficient Management of First line ALK-rearranged NSCLC - Part V
5.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation